EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis
(Part 3)
The reality is that managing the condition of patients who have difficult to treat rheumatoid arthritis
(D2T RA) provides a significant challenge among doctors.
For this reason, no specific guidance has been developed for the management of these kinds of patients.
Therefore, a European Alliance of Association for Rheumatology (EULAR) Task Force was convened to develop points to consider (PtC) for the management of D2T RA.
The convenor (GN) and co-convenor (JMvL) formed the Steering Committee and Task Force that followed the EULAR standardised operating procedures (SOPs).
The Steering Committee included the (co-) convenors, a methodologist (DvdH), a co-methodologist (PMJW), a rheumatology postdoctoral fellow and three fellows:
The Task Force comprised the Steering Committee members and another 18 rheumatologists, 3 patient partners, 1 rheumatology nurse, 1 rheumatology occupational therapist, 1 psychologist and 2 pharmacists.
All rheumatologists were experienced in the treatment of RA, the majority with significant experience in clinical trials and some also in outcomes research and patient registries.
We will be continuing this topic next week.